Efficacy of endoscopic nasobiliary drainage for the prevention of pancreatitis after papillary balloon dilatation: A pilot study

Pancreas

Volumn 31, Issue 1, 2005, Pages 93-97

  Sato, Daisuke ^a   Shibahara, Takeshi ^a   Miyazaki, Kaori ^a   Matsui, Hirohumi ^a   Yanaka, Akinori ^a   Nakahara, Akira ^a   Tanaka, Naomi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Nasobiliary drainage; Pancreatitis; Papillary balloon dilation

Indexed keywords

AMYLASE;

ADULT; AGED; AMYLASE BLOOD LEVEL; ARTICLE; BALLOON DILATATION; COMMON BILE DUCT STONE; DIAGNOSTIC TEST; ENDOSCOPIC NASOBILIARY DRAINAGE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPY; FEMALE; HUMAN; HYPERAMYLASEMIA; HYPOTHESIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PANCREATITIS; PRIORITY JOURNAL; RISK FACTOR; SURGICAL STRESS; TREATMENT OUTCOME;

ADULT; AGED; BALLOON DILATATION; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DRAINAGE; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL CAVITY; PANCREATITIS; PILOT PROJECTS; STENTS;

EID: 21344437505     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000163175.52297.a6     Document Type: Article

References (29)

1. Staritz M, Ewe K, Meyer zum Buschenfelde KH. Endoscopic papillary dilatation (EPD) for the treatment of common bile duct stones and papillary stenosis. Endoscopy. 1983;15:197-198.
2. Ueno N, Ozawa Y. Pancreatitis induced by endoscopic balloon sphincter dilation and the changes in serum amylase levels after the procedure. Gastrointest Endosc. 1999;49:472-476.
3. Minami A, Nakatsu T, Uchida N, et al. Papillary dilation vs sphincterotomy in endoscopic removal of bile duct stones. A randomized trial with manometric function. Dig Dis Sci. 1995;40:2550-2554.
4. Komatsu Y, Kawabe T, Toda N, et al. Endoscopic papillary balloon dilation for the management of common bile duct stones: Experience of 226 cases. Endoscopy. 1998;30:12-17.
5. Sato H, Kodama T, Takaaki J, et al. Endoscopic papillary balloon dilation may preserve sphincter of Oddi function after common bile duct stone management: evaluation from the viewpoint of endoscopic manometry. Gut. 1997;41:541-544.
6. Gary R, Peter B, Simon EJ, et al. Removal of stones from bile duct at ERCP without sphincterotomy. Gastrointest Endosc. 1993;39:749-754.
7. Mac Mathuna P, White P, Clarke E, et al. Endoscopic sphincteroplasty: a novel and safe alternative to papillotomy in the management of bile duct stones. Gut. 1994;35:127-129.
8. Mac Mathuna P, White P, Clarke E, et al. Endoscopic balloon sphincteroplasty (papillary dilatation) for bile duct stones: efficacy, safety, and follow-up in 100 patients. Gastrointest Endosc. 1995;42:468-474.
9. Ido K, Tamada K, Kimura K, et al. The role of endoscopic balloon sphincteroplasty in patients with gallbladder and bile duct stones. J Laparoendosc Adv Surg Tech. 1997;7:151-156.
10. Bergman JJGHM, Rauws EAJ, Fockens P, et al. Randomized trial of endoscopic balloon dilatation versus endoscopic sphincterotomy for removal of bileduct stones. Lancet. 1997;349:1124-1129.
11. Yasuda I, Tomita E, Moriwaki H, et al. Endoscopic papillary balloon dilatation for common bile duct stones: efficacy of combination with extracorporeal shockwave lithotripsy for large stones. Eur J Gastroenterol Hepatol. 1998;10:1045-1050.
12. Ueno N, Ozawa Y. Endoscopic sphincter dilatation in patients with bile duct stones: Immediate and medium-term results. J Gastroenterol Hepatol. 1999;14:822-826.
13. Cho YD, Moon JH, Lee MS, et al. Prospective analysis of endoscopic papillary balloon dilatation and endoscopic sphincterotomy for removal of common bile duct stones. Korean J Gastroenterol. 1999;33:258-267.
14. Bergman JJGHM, van Berkel AM, Bruno MJ, et al. Is endoscopic balloon dilatation for removal of bile duct stones associated with an increased risk for pancreatitis or a high rate of hyperamylasemia? Endoscopy. 2001;33:416-420.
15. Arnold JC, Benz C, Martin WR, et al. Endoscopic papillary-balloon dilatation vs. sphincterotomy for removal of common bile duct stones: a prospective randomized pilot study. Endoscopy. 2001;33:563;-567.
16. Natsui M, Narisawa R, Motoyama H, et al. What is an appropriate indication for endoscopic papillary balloon dilatation? Eur J Gastroenterol Hepatol. 2002;14:635-640.
17. Yao LQ, Zhang YQ, Zhou PH, et al. Endoscopic sphincterotomy or balloon dilatation for choledocholithiasis. Hepatobiliary Pancreat Dis Int. 2002;1:101-105.
18. Fujita N, Maguchi H, Komatsu Y, et al. Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones: a prospective randomized controlled multicenter trial. Gastrointest Endosc. 2003;57:151-155.
19. Sugiyama M, Izumisato Y, Abe N, et al. Predictive factors for acute pancreatitis and hyperamylasemia after endoscopic papillary balloon dilatation. Gastrointest Endosc. 2003;57:531-535.
20. DiSario JA, Freeman ML, Bjorkman DJ, et al. Endoscopic balloon dilation vs. sphincterotomy (EDES) for bile duct stone removal. Digestion. 1998;59(suppl 3):A26.
21. Cotton PB, Lehman G, Vennes G. Endoscopic sphincterotomy, complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383-393.
22. Bader M, Geenen JE, Hogan W, et al. Endoscopic balloon dilatation of the sphincter of Oddi in patients with suspected biliary dyskinesia: results of a prospective randomized trial. Gastrointest Endosc. 1986;32:AB158.
23. Kozarek RA. Balloon dilation of the sphincter of Oddi. Endoscopy. 1988;20:207-210.
24. Freeman ML, Nelson DB, Sherman S, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001;54:425-434.
25. Masci E, Toti G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP: a prospective, multicenter study. Am J Gastroenterol. 2001;96:417-423.
26. Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective, multicenter study. Gastrointest Endosc. 1998;48:1-10.
27. Sherman S, Ruffolo TA, Hawes RH, et al. Complications of endoscopic sphincterotomy: a prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated ducts. Gastroenterology. 1991;101:1068-1075.
28. Smithline A, Silverman W, Rogers D, et al. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy induced pancreatitis in high-risk patients. Gastrointest Endosc. 1993;39:652-657.
29. Paul R, Yuko Y, John T, et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of oddi dysfunction. Gastroenterology. 1998;115:1518-1524.